Abstract
Stress underlies the development of various psychiatric disorders. Rodent studies suggest an involvement of the endocannabinoid system in the modulation of the stress response, which needs to be translated to humans. In this study, 22 healthy males (mean age: M = 22.7 years) were exposed to a thermal heat stressor in a fear conditioning paradigm and blood samples of the circulating endocannabinoids anandamide and 2-arachidonoylglycerol (2-AG) were assessed. Additionally, electrodermal activity (EDA), task-related anxiety ratings and data on critical life experiences (CLE) were recorded. Interestingly, increases in 2-AG from pre-to-post stress correlated with: smaller stress responses (EDA), by trend more CLE, and greater conditioned anxiety. Smaller stress responses correlated with more CLE. We demonstrate a relation between endocannabinoid level changes from pre-to-post acute stress and the stress response. Our results suggest that investigating the role of 2-AG in the response to stress could be promising in finding treatments in the immediate aftermath of traumatic events.
Keywords: 2-Arachidonoylglycerol, Anandamide, Endocannabinoid system, FAAH C385A, Fear conditioning, Stress
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence.Alcohol Clin Exp Res. 2016 Nov;40(11):2426-2434. doi: 10.1111/acer.13210. Epub 2016 Sep 26.PMID: 27716956 Free PMC article.
-
Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety.J Neurosci. 2019 Feb 13;39(7):1275-1292. doi: 10.1523/JNEUROSCI.2251-18.2018. Epub 2018 Dec 20.PMID: 30573646 Free PMC article.
-
Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial.Biol Psychiatry. 2020 Mar 15;87(6):538-547. doi: 10.1016/j.biopsych.2019.07.034. Epub 2019 Aug 13.PMID: 31590924 Clinical Trial.
-
The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.CNS Neurol Disord Drug Targets. 2017;16(4):370-379. doi: 10.2174/1871527316666170223161908.PMID: 28240187 Review.
-
The endocannabinoid system in the amygdala and modulation of fear.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 8;105:110116. doi: 10.1016/j.pnpbp.2020.110116. Epub 2020 Sep 23.PMID: 32976951 Free PMC article. Review.